Clinical Study
Interleukin 18 as a Marker of Chronic Nephropathy in Children after Anticancer Treatment
Table 1
Connections between time of followup and signs of nephropathy, and glomerulopathy, tubulopathy.
| | Nephropathy | Glomerulopathy | Tubulopathy | Yes | No | | Yes | No | | Yes | No | |
| Time to followup (median of years; quartiles) | 4.03 (2.34–7.17) | 5.17 (3.67–7.38) | 0.0786 | 4.63 (2.59–8.12) | 4.42 (3.25–6.08) | 0.8889 |
3.43 (1.79–4.97) | 5.13 (3.48–4.97) | 0.0039 |
|
|